Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.
COMMENTARY
Market Review
Global equity markets made positive gains in March.
The US Federal Reserve kept its benchmark rate unchanged at 5.25 – 5.50% for the fifth consecutive meeting, while continuing to signal three rate cuts this year. Both the Bank of England and European Central Bank also kept rates unchanged. However, the Swiss National Bank unexpectedly reduced interest rates by 0.25% to 1.50% as inflation returned to the bank’s target range.
The Bank of Japan raised short-term interest rates, ending the country’s decade-long era of negative interest rates. In contrast, the People’s Bank of China introduced measures to re-invigorate its moribund economy, including reducing the cash-reserve requirements for banks, freeing up more funds for lending.
European stocks also outperformed, led by strong returns in Spain, Italy, and Denmark. Pacific ex-Japan stocks underperformed, impacted by poor returns in Hong Kong, which were weighed down by ongoing economic weakness on the Chinese mainland. Poor returns in China also detracted from returns in emerging markets, although this was offset by strong performance in Taiwan and South Korea.
Energy and Materials were the strongest performing sectors, aided by higher oil and precious metal prices. Consumer discretionary and consumer staples were the weakest performing sectors. Information Technology also underperformed, dragged down by the poor performance of index heavyweights like Apple.
Portfolio Commentary
The Fund underperformed the benchmark during March. Value stocks outperformed growth as the share market recovery broadened, following strong outperformance by growth companies at the start of the year. Strong performance by the Fund’s holdings in materials and real estate and the underweight position in consumer discretionary boosted relative returns. However, this was offset by weaker performance by the Fund’s holdings in information technology, healthcare and financials.
The Fund is focussed on identifying great companies through bottom-up analysis and continues to identify exciting opportunities in health care, communications services and industrials, in which it maintains overweight positions.
The strongest contributor to relative returns during March was the overweight position in US-based agricultural equipment manufacturer Deere. The stock outperformed upon rising sentiment in the agricultural sector, driven by stronger commodity prices, which should support increased capital investment.
The US-based global technology group Alphabet outperformed after announcing it was in talks with Apple to include Google’s Gemini AI technology into the iPhone. This would help Google maintain its market leading position in internet search.
The Fund’s holding in US-based Vertex Pharmaceuticals detracted from relative returns in March. This followed concerns around a lull in its drug development pipeline and progress on its phase 3 trial for an acute pain treatment.
Hong Kong-based China life insurer AIA Group also detracted from the Fund’s relative performance. Weakness in China’s economy has impacted investor sentiment across the Hong Kong and China stock markets. Investors were further disappointed when it failed to announce more stock repurchases.
The Fund established a new position in US-based Booking Holdings, an online travel agency which owns brands such as Booking.com, Priceline and Agoda. It benefits from an experienced management team, positive free cash flow generation and a strong competitive position in the US, European, and Asian markets. The global travel market remains fragmented, with only about half of total bookings made online. Continuing adoption of online booking and the company’s recent expansion into airline tickets and alternative accommodation are expected to drive future earnings growth.
The Fund also opened a new position in US-listed – but Argentina-based – Globant. The company specialises in designing and building cloud applications, data-analytics solutions, cybersecurity solutions, and mobile-optimised user interfaces. The company helps customers improve their digital interactions as businesses undertake major digital transformation initiatives to better engage with customers, counterparties and employees. Rising corporate demand for digital solutions and Globant’s ability to win market share is expected to drive earnings growth over the next decade.